•Multiple law firms are investigating the fairness of the acquisition price for Leggett & Platt by Somnigroup International Inc.
•Leggett & Platt shareholders are set to receive 0.1455 shares of Somnigroup common stock for each share held.
•The merger of Pulmatrix, Inc. and Eos SENOLYTIX, Inc. is also under investigation, with Pulmatrix stockholders expected to own approximately 6% of the combined company.
•Law firms announced lead plaintiff deadlines for class action lawsuits against Stellantis, Soleno Therapeutics, ImmunityBio, Camping World, uniQure, and PomDoctor.
•The lawsuits involve alleged violations of federal securities laws and significant investor losses during specific class periods in 2025 and 2026.